Stoke Therapeutics Balance Sheet (2022-2025) | STOK

Balance Sheet Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Accumulated Depreciation 4.21M6.67M8.85M
Assets
Current Assets
Cash & Equivalents 84.11M67.75M113.40M113.56M190.34M192.06M189.98M191.44M178.58M193.48M150.02M127.98M274.82M101.47M83.39M
Receivables - Net 1.67M9.25M
Receivables - Other 0.27M0.35M0.40M0.59M0.49M0.14M0.10M0.06M0.01M0.30M0.69M0.70M0.61M1.62M1.59M
Receivables 2.37M10.84M
Prepaid Assets 12.29M13.18M12.55M10.93M10.19M10.95M10.94M11.32M10.72M10.35M9.84M11.12M12.69M13.69M7.75M
Current Deferred Tax Assets 0.40M
Current Assets 305.77M289.16M264.60M244.07M270.24M246.23M230.02M215.34M193.28M296.99M253.61M232.76M375.74M269.97M272.44M
Non-Current Assets
Property, Plant & Equipment (Net) 5.04M5.87M7.16M6.67M6.79M6.47M6.22M5.82M5.28M4.77M4.33M3.91M3.61M3.34M3.08M
Long-Term Investments 29.95M29.82M22.99M107.26M80.31M
Other Non-Current Assets 0.57M0.57M0.57M0.57M0.57M0.57M0.57M0.57M0.57M0.49M0.49M0.72M0.72M0.72M0.72M
Non-Current Assets 10.17M12.27M13.03M12.00M11.56M10.69M9.87M13.00M11.91M10.76M39.71M38.80M31.15M114.54M87.83M
Assets 315.94M301.43M277.63M256.07M281.80M256.92M239.89M228.34M205.18M307.76M293.32M271.56M406.89M384.51M360.26M
Liabilities
Current Liabilities
Accounts Payables 3.33M3.60M1.91M0.77M4.30M1.56M3.08M1.70M2.10M3.94M2.48M2.50M2.19M4.31M5.87M
Payables 3.33M3.60M1.91M0.77M4.30M1.56M3.08M1.70M2.10M3.94M2.48M2.50M2.19M4.31M5.87M
Accumulated Expenses 11.11M13.41M14.05M15.75M13.78M12.22M13.39M13.81M12.57M14.50M15.77M18.57M24.34M25.62M30.09M
Other Accumulated Expenses 0.52M0.75M0.43M0.51M0.51M0.70M0.47M0.86M0.98M1.04M0.60M0.75M2.07M1.75M0.80M
Current Deferred Revenue 8.47M10.63M12.84M14.88M13.45M8.06M8.73M15.31M20.92M26.05M31.61M18.99M18.16M8.75M5.76M
Total Current Liabilities 22.91M27.65M28.80M31.39M31.53M21.84M25.20M30.82M35.59M44.50M49.87M40.06M44.69M38.68M41.73M
Non-Current Liabilities
Non-Current Deffered Revenue 49.55M45.21M41.08M36.86M34.14M43.26M40.73M33.07M25.04M16.95M8.29M10.26M9.63M8.56M
Other Non-Current Liabilities 3.51M4.25M3.61M2.97M2.30M1.63M0.96M4.88M4.21M3.61M3.05M2.48M1.87M1.25M1.87M
Total Non-Current Liabilities 53.06M49.46M44.69M39.82M36.45M44.89M41.69M37.96M29.25M20.55M11.34M2.48M12.13M10.89M10.43M
Total Liabilities 75.96M77.11M73.48M71.22M67.97M66.72M66.89M68.78M64.84M65.05M61.21M42.53M56.81M49.56M52.16M
Shareholder's Equity
Common Equity 239.98M224.32M204.14M184.85M213.82M190.19M173.00M159.56M140.34M242.71M232.11M229.02M350.07M334.94M308.11M
Shareholder's Equity 239.98M224.32M204.14M184.85M213.82M190.19M173.00M159.56M140.34M242.71M232.11M229.02M350.07M334.94M308.11M
Liabilities and Shareholders Equity 315.94M301.43M277.63M256.07M281.80M256.92M239.89M228.34M205.18M307.76M293.32M271.56M406.89M384.51M360.26M
Retained Earnings -220.73M-245.38M-271.50M-297.15M-319.69M-350.35M-374.89M-401.85M-428.22M-453.92M-480.35M-490.83M-377.95M-401.43M-439.78M
Treasury Shares 1.51M1.22M
Shares Outstanding 39.04M39.38M39.43M39.44M44.18M44.20M44.29M45.92M46.50M52.31M52.94M54.03M54.60M54.72M55.12M